Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Post by general360on Nov 19, 2020 9:54am
873 Views
Post# 31930014

exactly 1 yr ago...

exactly 1 yr ago...its been a FULL YEAR since "Oh, but we do......"  Nov 18 2019.  One full, long, agonizing year with 1 fwd looking statement after another....

"Resverlogix to Hold BETonMACE Conference Call and Webcast on November 18, 2019"
https://www.resverlogix.com/investors/news?article=649

US thanksgiving is next week, so it looks like nothing is going to happen, buh-bye November 2020... unless we shock the world and have a NR Monday Nov 30 which is UNLIKELY.... gonna all come down to the wire in Dec?  nothing by AGM?  boy oh boy do i hope we get the chance to ask questions!

a few more papers published, a few dribs and drabs of additional info along the way, but thats about it. SP languishing, waiting for an elusive deal...."by year end" "oh but we do..."

time to start sharpening the pitchforks?

<< Previous
Bullboard Posts
Next >>